Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Nautamine
2. Diphenhydramine Di(acefyllinate)
3. F3d8g86a29
4. 6888-11-5
5. 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetic Acid Compd With 2-(diphenylmethoxy)-n,n-dimethylethanamine (2:1)
6. O-benzhydryldimethylaminoethanol Bis(theophylline 7-acetate)
7. Schembl49392
8. Unii-f3d8g86a29
9. Diphenhydramine Acefyllinate
10. Diphenhydramine Diacefyllinate
11. Diphenhydramine Acefyllinate [who-dd]
12. Diphenhydramine Di(acefyllinate) [mi]
13. Diphenhydramine Di(acefyllinate) [mart.]
14. Q27277582
| Molecular Weight | 731.8 g/mol |
|---|---|
| Molecular Formula | C35H41N9O9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 10 |
| Exact Mass | 731.30272392 g/mol |
| Monoisotopic Mass | 731.30272392 g/mol |
| Topological Polar Surface Area | 204 Ų |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 597 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A Diacefylline Diphenhydramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diacefylline Diphenhydramine, including repackagers and relabelers. The FDA regulates Diacefylline Diphenhydramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diacefylline Diphenhydramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diacefylline Diphenhydramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diacefylline Diphenhydramine supplier is an individual or a company that provides Diacefylline Diphenhydramine active pharmaceutical ingredient (API) or Diacefylline Diphenhydramine finished formulations upon request. The Diacefylline Diphenhydramine suppliers may include Diacefylline Diphenhydramine API manufacturers, exporters, distributors and traders.
click here to find a list of Diacefylline Diphenhydramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Diacefylline Diphenhydramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diacefylline Diphenhydramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diacefylline Diphenhydramine GMP manufacturer or Diacefylline Diphenhydramine GMP API supplier for your needs.
A Diacefylline Diphenhydramine CoA (Certificate of Analysis) is a formal document that attests to Diacefylline Diphenhydramine's compliance with Diacefylline Diphenhydramine specifications and serves as a tool for batch-level quality control.
Diacefylline Diphenhydramine CoA mostly includes findings from lab analyses of a specific batch. For each Diacefylline Diphenhydramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diacefylline Diphenhydramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Diacefylline Diphenhydramine EP), Diacefylline Diphenhydramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diacefylline Diphenhydramine USP).
LOOKING FOR A SUPPLIER?
